In Vitro Inhibitory Effects of Hinokitiol on Proliferation of Chlamydia trachomatis

ABSTRACT The inhibitory effects of hinokitiol (β-thujaplicin) on Chlamydia trachomatis D/UW-3/Cx were shown by MIC, minimum lethal concentration (MLC), and preinoculation minimal microbicidal concentration assays using HeLa 229 cells. The MIC and the MLC were both 32 μg/ml. Further evaluation of hinokitiol as a topical agent against C. trachomatis is warranted.

[1]  A. Osanai,et al.  Transmission electron microscopy of Schistosoma mansoni cercariae treated with hinokitiol (beta-thujaplicin), a compound for potential skin application against cercarial penetration. , 2004, The Tohoku journal of experimental medicine.

[2]  Y. Hara,et al.  In vitro inhibitory effects of tea polyphenols on the proliferation of Chlamydia trachomatis and Chlamydia pneumoniae. , 2003, Japanese journal of infectious diseases.

[3]  R. Hayakawa,et al.  Antibacterial effect of beta-thujaplicin on staphylococci isolated from atopic dermatitis: relationship between changes in the number of viable bacterial cells and clinical improvement in an eczematous lesion of atopic dermatitis. , 2003, The Journal of antimicrobial chemotherapy.

[4]  D. Taylor-Robinson,et al.  In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride. , 2001, Journal of Antimicrobial Chemotherapy.

[5]  W. Stamm.  Potential for antimicrobial resistance in Chlamydia pneumoniae. , 2000, The Journal of infectious diseases.

[6]  K. Workowski,et al.  Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. , 2000, The Journal of infectious diseases.

[7]  Y. Sakagami,et al.  Antimicrobial activity and metalloprotease inhibition of hinokitiol-related compounds, the constituents of Thujopsis dolabrata S. and Z. hondai MAK. , 1999, Biological & pharmaceutical bulletin.

[8]  D. Miyamoto,et al.  Thujaplicin-copper chelates inhibit replication of human influenza viruses. , 1998, Antiviral research.

[9]  W. Stamm,et al.  Susceptibility of Chlamydia trachomatisto Chlorhexidine Gluconate Gel , 1998, Antimicrobial Agents and Chemotherapy.

[10]  Chlamydia trachomatis genital infections--United States, 1995. , 1998, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[11]  Y. Sakagami,et al.  Biological activity of purpurogallin. , 1997, Bioscience, biotechnology, and biochemistry.

[12]  Morie M. Higgins Peter M. Jenkins,et al.  Chlamydia trachomatis genital infections--United States, 1995. , 1997, MMWR. Morbidity and mortality weekly report.

[13]  D. Martin,et al.  Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. , 1990, The Journal of infectious diseases.

[14]  Y. Ito,et al.  Antimicrobial action of natural substances on oral bacteria. , 1989, The Bulletin of Tokyo Dental College.

[15]  J. Kelly,et al.  In vitro activity of the spermicide nonoxynol-9 against Chlamydia trachomatis , 1985, Antimicrobial Agents and Chemotherapy.

[16]  W. Mccormack,et al.  Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro , 1985, Antimicrobial Agents and Chemotherapy.

[17]  H. Erdtman,et al.  Antibiotic Substances from the Heart Wood of Thuja Plicata Don. , 1948, Nature.